Covidien plc (NYSE: COV) has acquired medical device maker Sapheon Inc. for an undisclosed amount.

Sapheon, headquartered in Morrisville, North Carolina, develops and manufactures the VenaSeal system, which is used to treat patients with varicose veins.

Covidien says that the acquisition will help it to provide more treatment options for doctors.

In June, Medtronic Inc. agreed to buy Covidien in a $42.9 billion deal. 

The Dublin-based medical device company won Mergers & Acquisitions M&A Mid-Market Strategic Buyer of the Year award for 2012 after scooping up a bunch of medical device companies. 

For more on medical devices, see "Medical Devices Drive Health Care M&A." For more on health care, see "5 Technologies Drive Health Care M&A." 

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.